financetom
Business
financetom
/
Business
/
Ami Organics management explains semiconductor biz foray with Baba Chemicals acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ami Organics management explains semiconductor biz foray with Baba Chemicals acquisition
Apr 25, 2023 3:07 AM

Ami Organics has announced it foray into the semiconductor space. Company has acquired majority stake in speciality chemicals maker Baba Fine Chemicals (BFC). BFC is engaged in the business of manufacturing specialty chemicals used in the semiconductor and electronics industry.

Share Market Live

NSE

Naresh Patel, Executive Chairman and Managing Director at Ami Organics shared some insights on the acquisition and the growth potential of Baba Fine Chemicals in an interview with CNBC-TV18.

“This acquisition is in-line with our strategy to enhance our fine chemical portfolio and both BFC and Ami Organics has a very good product profile and that will make us grow in future,” he said.

Notably, BFC has reported revenue of around Rs 47 crore in financial year 2023, Rs 36.6 crore in financial year 2022 and Rs 26.4 crore in financial year 2021.

According to Patel, the revenue can be higher by 5-6 times in the next few years. Patel also mentioned that the margin for the acquired asset is around 40 percent, which is quite attractive.

“Revenue can be easily go up to 5-6 fold in next three, four years and margins will be little suppressed, will remain around 40 percent,” he said.

Also Read | Ami Organics to foray into semiconductor industry through its latest acquisition

Patel further stated that Ami Organics plans to increase its stake to 100 percent in Baba Chemicals, which is a net debt-free company.

“In the near future, that is the plan. Currently, we are happy with the controlling stake and sooner or later we will go to have a better positioning in the company,” he added.

He believes that the acquisition of Baba Chemicals will help Ami Organics expand its presence in the high barrier semiconductor industry.

The semiconductor industry is known for its high barriers to entry due to its complex processes and high capital requirements. However, Patel believes that Ami Organics is well-positioned to enter this market with the acquisition of Baba Chemicals.

Also Read | First semiconductor fab will be declared in a few weeks: IT Minister Ashwini Vaishnaw

Patel also highlighted that the main customers for semiconductor chemicals are in the US market. However, he believes that there is a significant growth potential in other markets such as Korea, Taiwan, and Japan. With Baba Chemicals' expertise in the semiconductor industry and Ami Organics' strong presence in the specialty chemicals market, the company can target these markets and grow its business.

Also Read | South Korea, Japan announce plan to resolve dispute over wartime forced labor

For more details, watch the accompanying video

Catch all the latest updates from the stock market here

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GR Silver Mining Upsizes Private Placement Financing to $2.4 Million
GR Silver Mining Upsizes Private Placement Financing to $2.4 Million
Sep 18, 2024
03:58 PM EDT, 09/17/2024 (MT Newswires) -- GR Silver Mining ( GRSLF ) said Tuesday it is upsizing a private placement offering due to additional interest. The company will now offer up to 15-million units at $0.16 each, aiming to raise up to $2.4 million in gross proceeds. This is an increase from the previous plan to offer 12.5-million units...
Powell Industries Insider Sold Shares Worth $467,524, According to a Recent SEC Filing
Powell Industries Insider Sold Shares Worth $467,524, According to a Recent SEC Filing
Sep 18, 2024
04:23 PM EDT, 09/17/2024 (MT Newswires) -- Brett Alan Cope, Director, President & CEO, on September 13, 2024, sold 2,750 shares in Powell Industries ( POWL ) for $467,524. Following the Form 4 filing with the SEC, Cope has control over a total of 143,237 shares of the company, with 143,237 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/80420/000008042024000068/xslF345X05/wk-form4_1726604348.xml ...
Cytokinetics Insider Sold Shares Worth $414,401, According to a Recent SEC Filing
Cytokinetics Insider Sold Shares Worth $414,401, According to a Recent SEC Filing
Sep 18, 2024
04:23 PM EDT, 09/17/2024 (MT Newswires) -- Fady Ibraham Malik, Executive Vice President, Research & Development, on September 17, 2024, sold 7,300 shares in Cytokinetics ( CYTK ) for $414,401. Following the Form 4 filing with the SEC, Malik has control over a total of 120,920 shares of the company, with 120,920 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000112760224024083/xslF345X05/form4.xml ...
Structure Therapeutics Names Chief Medical Officer, Chief Development Officer
Structure Therapeutics Names Chief Medical Officer, Chief Development Officer
Sep 18, 2024
04:23 PM EDT, 09/17/2024 (MT Newswires) -- Structure Therapeutics ( GPCR ) said late Tuesday it has promoted Blai Coll to chief medical officer, replacing Mark Bach as part of a planned succession, effective Sept. 18. Coll has been vice president of clinical development at Structure since 2022, the company said. Additionally, Ashley Hall has been appointed to the newly...
Copyright 2023-2026 - www.financetom.com All Rights Reserved